UBS Group
IVA

UBS Group’s Inventiva IVA Stock Holding History

UBS Group’s Portfolio IVA Stock Details IVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.9M Sell
2,318,693
-325,009
-12% -$1.98M ﹤0.01% 3082
2025
Q4 		$12.3M Buy
2,643,702
+2,634,580
+28,882% +$12.2M ﹤0.01% 3076
2025
Q3 		$52.8K Sell
9,122
-18,326
-67% -$79.9K ﹤0.01% 7523
2025
Q2 		$87.6K Buy
27,448
+26,740
+3,777% +$90.5K ﹤0.01% 7340
2025
Q1 		$2.08K Sell
708
-608,537
-100% -$1.6M ﹤0.01% 9397
2024
Q4 		$1.3M Buy
+609,245
New +$1.5M ﹤0.01% 5111
2024
Q3 		– Sell
-10,649
Closed -$31.8K – 9783
2024
Q2 		$31.8K Buy
10,649
+10,507
+7,399% +$35.7K ﹤0.01% 7023
2024
Q1 		$514 Sell
142
-112
-44% -$433 ﹤0.01% 8507
2023
Q4 		$1.15K Buy
+254
New +$1.03K ﹤0.01% 8394
2023
Q3 		– Sell
-34
Closed -$137 – 9709
2023
Q2 		$137 Buy
+34
New +$112 ﹤0.01% 8455
2022
Q4 		– Sell
-2,593
Closed -$10K – 10926
2022
Q3 		$10K Buy
2,593
+291
+13% +$1.36K ﹤0.01% 8429
2022
Q2 		$13K Buy
2,302
+1,025
+80% +$9.32K ﹤0.01% 7514
2022
Q1 		$14K Buy
1,277
+738
+137% +$8.97K ﹤0.01% 7945
2021
Q4 		$7K Sell
539
-758
-58% -$10.5K ﹤0.01% 9152
2021
Q3 		$18K Buy
1,297
+900
+227% +$11.9K ﹤0.01% 7283
2021
Q2 		$5K Buy
+397
New +$5.62K ﹤0.01% 8549
2021
Q1 		– Sell
-749
Closed -$11K – 9235
2020
Q4 		$11K Buy
+749
New +$9.71K ﹤0.01% 7409

Other funds holding IVA

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM

UBS Group's IVA Position: Q1 2026 in Review

UBS Group reduced its Inventiva (IVA) stake by 12% in Q1 2026, selling an estimated $1.98M and leaving 2,318,693 shares worth $12.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3082.

UBS Group first reported a position in IVA in Q4 2020 and has held it in 17 quarters since. 65 funds tracked by Wall St. Rank hold IVA as of Q1 2026.

  • UBS Group held 2,318,693 shares of Inventiva worth $12.9M as of Q1 2026.
  • UBS Group sold 325,009 Inventiva shares in Q1 2026, an estimated $1.98M.
  • Inventiva made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3082 holding.
  • UBS Group first reported a position in Inventiva in Q4 2020 and has held it in 17 quarters since.
  • 65 funds tracked by Wall St. Rank held Inventiva as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.